Accenture is a leading global professional services company that helps clients to build their digital core, transform their operations, and accelerate revenue growth by creating tangible value across their enterprises at speed and scale. Years of investment, in digital, cloud & security strategy, have helped Accenture to evolve as a trusted and viable consulting services provider. Accenture's clients comprise the Fortune Global 100 and the Fortune Global 500. The ability to anticipate large, transformative technology trends and capitalization through mergers and acquisitions, are the keys to the company's success. Accenture reports under five segments: Communications, Media & Technology, Financial Services, Health & Public Service, Products, and Resources. The company's integrated service team meets client needs rapidly and at scale, leveraging Accenture's network of innovation hubs, the company's technology expertise and ecosystem relationships, and our global delivery capabilities....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 31 January 2026
2021-07-07 05:22:00 Wednesday ET

What are the best online stock market investment tools? Stock trading has seen an explosion since the start of the pandemic. As people lost their jobs an
2018-12-21 11:39:00 Friday ET

The Internet and telecom conglomerate SoftBank Group raises $23 billion in the biggest IPO in Japan. Going public is part of the major corporate move away f
2019-02-11 09:37:00 Monday ET

Corporate America uses Trump tax cuts and offshore cash stockpiles primarily to fund share repurchases for better stock market valuation. Share repurchases
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-11-21 11:34:00 Thursday ET

Berkeley macro economist Brad DeLong sees no good reasons for an imminent economic recession with mass unemployment and even depression. The current U.S. ec
2019-06-05 10:34:00 Wednesday ET

Fed Chair Jay Powell suggests that the recent surge in U.S. business debt poses moderate risks to the economy. Many corporate treasuries now carry about 40%